301089 Share Price Performance
CN¥0
-29.39 (-100.00%)
Price CN¥0
Share Pricen/a
Tuoxin Pharmaceutical Group Co.,Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
301089 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Tuoxin Pharmaceutical Group Co.,Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Mar 28, 2026
- -0.37
- 29.45%
- -12.90%
- 0%
About 301089
- Founded
- 2001
- Employees
- 1551
- CEO
- WebsiteView website
Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series; nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, azithromycin, cytosine, 5-fluorocytosine, cytidine, uridine; and other APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. The company was founded in 2001 and is based in Xinxiang, China.
